Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 2/20 | 0.41 |
| ▸ | RARG | P13631 | 2/20 | 0.41 |
| ▸ | RARA | P10276 | 1/20 | 0.41 |
| ▸ | HSPA9 | P38646 | 4/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
| ▸ | TGM2 | P21980 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | PNMT | P11086 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19859121 | 0.90 | RARB (0.49) | RARBRARGRARAHSPA9AR | |
| SCHEMBL15304427 | 0.81 | RARB (0.42) | RARBRARGRARAHSPA9AR | |
| SCHEMBL2061994 | 0.80 | RARB (0.41) | RARBRARGRARAHSPA9AR | |
| SCHEMBL24103467 | 0.80 | HTR2A (0.47) | RARBRARGRARAHSPA9 | |
| SCHEMBL14199202 | 0.78 | RARB (0.42) | RARBRARGRARAHSPA9AR | |
| SCHEMBL395241 | 0.75 | KDM1A (0.46) | RARBRARGRARAHSPA9 | |
| SCHEMBL2060732 | 0.75 | HSPA9 (0.57) | RARBRARGRARAHSPA9ADRA2A | |
| SCHEMBL12693461 | 0.71 | RARB (0.42) | RARBRARGRARAAR | |
| SCHEMBL24103460 | 0.71 | — | — | |
| SCHEMBL3714772 | 0.70 | RARB (0.50) | RARBRARGRARAHSPA9AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2684874-B1 | Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors | CEPHALON INC (US) | 2017-05-17 | — | — | EP | disclosed |
| EP-2684874-A1 | Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors | Cephalon, Inc. (US) | 2014-01-15 | — | — | EP | disclosed |